Recent studies indicate that these cells are scarce in CRC tissue since the early stages, compared to nonmalignant colonic tissue, and that a decreased number of CD56+ cells in patients with CRC is associated with an increased frequency of cancer recurrence [21]–[24]. This evidence concerns the gene NCAM1 and colorectal carcinoma.